IUPHAR themed review: Opioid efficacy, bias, and selectivity
Drugs acting at the opioid receptor family are clinically used to treat chronic and acute pain, though they represent the second line of treatment behind GABA analogs, antidepressants and SSRI's. Within the opioid family mu and kappa opioid receptor are commonly targeted. However, activation of...
Saved in:
Main Authors: | Nokomis Ramos-Gonzalez (Author), Barnali Paul (Author), Susruta Majumdar (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2023-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
IUPHAR Review - Bivalent and bifunctional opioid receptor ligands as novel analgesics
by: Kyle J. Rehrauer, et al.
Published: (2023) -
IUPHAR review - Data-driven computational drug repurposing approaches for opioid use disorder
by: Zhenxiang Gao, et al.
Published: (2024) -
IUPHAR review: Navigating the role of preclinical models in pain research
by: Seyed Asaad Karimi, et al.
Published: (2024) -
IUPHAR Review: New strategies for medications to treat substance use disorders
by: Ivan D. Montoya, et al.
Published: (2024) -
IUPHAR - invited review - Ibogaine - A legacy within the current renaissance of psychedelic therapy
by: Deborah C. Mash
Published: (2023)